169 related articles for article (PubMed ID: 21044089)
1. A non-human primate model for analysis of safety, persistence, and function of adoptively transferred T cells.
Berger C; Berger M; Anderson D; Riddell SR
J Med Primatol; 2011 Apr; 40(2):88-103. PubMed ID: 21044089
[TBL] [Abstract][Full Text] [Related]
2. Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates.
Berger C; Jensen MC; Lansdorp PM; Gough M; Elliott C; Riddell SR
J Clin Invest; 2008 Jan; 118(1):294-305. PubMed ID: 18060041
[TBL] [Abstract][Full Text] [Related]
3. Proliferation-linked apoptosis of adoptively transferred T cells after IL-15 administration in macaques.
Berger C; Berger M; Beard BC; Kiem HP; Gooley TA; Riddell SR
PLoS One; 2013; 8(2):e56268. PubMed ID: 23418547
[TBL] [Abstract][Full Text] [Related]
4. Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice.
Wang X; Berger C; Wong CW; Forman SJ; Riddell SR; Jensen MC
Blood; 2011 Feb; 117(6):1888-98. PubMed ID: 21123821
[TBL] [Abstract][Full Text] [Related]
5. Memory T cells specific for murine cytomegalovirus re-emerge after multiple challenges and recapitulate immunity in various adoptive transfer scenarios.
Quinn M; Turula H; Tandon M; Deslouches B; Moghbeli T; Snyder CM
J Immunol; 2015 Feb; 194(4):1726-1736. PubMed ID: 25595792
[TBL] [Abstract][Full Text] [Related]
6. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
7. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells.
Yee C; Thompson JA; Byrd D; Riddell SR; Roche P; Celis E; Greenberg PD
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16168-73. PubMed ID: 12427970
[TBL] [Abstract][Full Text] [Related]
8. Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cells.
Qiu F; Jiang P; Zhang G; An J; Ruan K; Lyu X; Zhou J; Sheng W
Nat Commun; 2024 May; 15(1):4327. PubMed ID: 38773088
[TBL] [Abstract][Full Text] [Related]
9. Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity.
Hinrichs CS; Borman ZA; Cassard L; Gattinoni L; Spolski R; Yu Z; Sanchez-Perez L; Muranski P; Kern SJ; Logun C; Palmer DC; Ji Y; Reger RN; Leonard WJ; Danner RL; Rosenberg SA; Restifo NP
Proc Natl Acad Sci U S A; 2009 Oct; 106(41):17469-74. PubMed ID: 19805141
[TBL] [Abstract][Full Text] [Related]
10. Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans.
Jensen MC; Popplewell L; Cooper LJ; DiGiusto D; Kalos M; Ostberg JR; Forman SJ
Biol Blood Marrow Transplant; 2010 Sep; 16(9):1245-56. PubMed ID: 20304086
[TBL] [Abstract][Full Text] [Related]
11. Detailed analysis of cytomegalovirus (CMV)-specific T cells expanded for adoptive immunotherapy of CMV infection following allogeneic stem cell transplantation for malignant disease.
Hobeika A; Osada T; Serra D; Peplinski S; Hanson K; Tanaka Y; Niedzwiecki D; Chao N; Rizzieri D; Lyerly H; Clay T; Morse M
Cytotherapy; 2008; 10(3):289-302. PubMed ID: 18418774
[TBL] [Abstract][Full Text] [Related]
12. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
[TBL] [Abstract][Full Text] [Related]
13. Tumor-Specific Effector CD8+ T Cells That Can Establish Immunological Memory in Humans after Adoptive Transfer Are Marked by Expression of IL7 Receptor and c-myc.
Chandran SS; Paria BC; Srivastava AK; Rothermel LD; Stephens DJ; Kammula US
Cancer Res; 2015 Aug; 75(16):3216-26. PubMed ID: 26100671
[TBL] [Abstract][Full Text] [Related]
14. T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells.
Zah E; Lin MY; Silva-Benedict A; Jensen MC; Chen YY
Cancer Immunol Res; 2016 Jun; 4(6):498-508. PubMed ID: 27059623
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of Specific CD4+ and CD8+ T Cells Stimulated by CMV pp65 and IE1 Antigens.
Albiero E; Amati E; Baumeister E; Einsele H; Grigoleit GU; Rodeghiero F
J Immunother; 2016; 39(9):329-342. PubMed ID: 27631893
[TBL] [Abstract][Full Text] [Related]
16. Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy.
Zandvliet ML; van Liempt E; Jedema I; Veltrop-Duits LA; Willemze R; Guchelaar HJ; Falkenburg JH; Meij P
Cytotherapy; 2010 Nov; 12(7):933-44. PubMed ID: 20078388
[TBL] [Abstract][Full Text] [Related]
17. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.
Walter EA; Greenberg PD; Gilbert MJ; Finch RJ; Watanabe KS; Thomas ED; Riddell SR
N Engl J Med; 1995 Oct; 333(16):1038-44. PubMed ID: 7675046
[TBL] [Abstract][Full Text] [Related]
18. Principles for adoptive T cell therapy of human viral diseases.
Riddell SR; Greenberg PD
Annu Rev Immunol; 1995; 13():545-86. PubMed ID: 7612234
[TBL] [Abstract][Full Text] [Related]
19. Imaging of cytotoxic antiviral immunity while considering the 3R principle of animal research.
Otto L; Zelinskyy G; Schuster M; Dittmer U; Gunzer M
J Mol Med (Berl); 2018 Apr; 96(3-4):349-360. PubMed ID: 29460050
[TBL] [Abstract][Full Text] [Related]
20. Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8
Hasan AN; Selvakumar A; Shabrova E; Liu XR; Afridi F; Heller G; Riviere I; Sadelain M; Dupont B; O'Reilly RJ
Clin Exp Immunol; 2016 Nov; 186(2):249-265. PubMed ID: 27227483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]